Clay Seigall is Founder, CEO, Chairman, and President of Seattle Genetics. He began the company in 1998. Since then he’s accrued multiple channels of research funding for the company. Clay Seigall may be best known for helping Seattle Genetics create cancer therapies that use antibodies to fight the disease. Mr. Seigall was recently mentioned in a local Seattle magazine. They focused on the success of his business and wondered what it would mean for the company’s future.
Seattle Genetics has grown into a top biotech firm. They research and experiment with human antibodies. The business’ building even looks like the basic shape of an antibody. These are used in treatments to eradicate dangerous cancer cells. Their main cancer drug is called Adcetris. It treats cancer of the lymph system that easily spreads. If this treatment continues to show success then it could become very popular.
Seattle Genetics employs over 900 people. They only expect to add employees in the near future. Their net worth has grown to almost ten billion dollars under the leadership of Clay Siegall. He’s explained that he didn’t plan on selling. His plans have only focused on building an amazing company. He has done just that. Seattle Genetics earned sales of over 418 million dollars in 2016. He sees the goal of the company and doesn’t let anything get in the way of its success.
Clay Seigall holds a Bachelors of Science in Zoology. He also received a Ph.D. in Genetics from George Washington University. He was also a finalist for the Ernst and Young Pacific Northwest Entrepreneur of the Year award in the early 2000s. He holds multiple patents and serves on the Board of Directors for Ultragenyx Pharmaceutical. Before his time at Seattle Genetics, Clay Seigall worked with the National Cancer Institute, National Institute of Health, and the Bristol-Myers Squibb Pharmaceutical Research Institute. His work was widely inspired by his father’s untimely death when Mr. Seigall was 24. He died of cancer, and that’s when Clay Seigall began to understand the need for effective cancer treatments.
His first goal as the leader of Seattle Genetics is to help people. His views are practical, yet philosophical. He’s stated that he truly loves his job. His combined experience, education, and passion have kept him in the industry for thirty years. He continues to lead technological research and development to improve the tools used for treating cancer.